Rebastinib (DCC-2036) is a conformational control Bcr-Abl inhibitor for Abl1(WT) and Abl1(T315I) with IC50 of 0.8 nM and 4 nM, also inhibits SRC, LYN, FGR, HCK, KDR, FLT3, and Tie-2, and low activity to seen towards c-Kit. Phase 1.
| Quantity | 100mg, 500mg, 1 g |
|---|
Be the first to review “Rebastinib (DCC-2036)”
Related products
Sale!
Powder for Hairloss Treatment Research
Price range: $100.00 through $500.00
Powder for Hairloss Treatment Research
Price range: $25.00 through $75.00
Sale!
Powder for Hairloss Treatment Research
Price range: $320.00 through $2,800.00
Sale!
Powder for Hairloss Treatment Research
Price range: $165.00 through $255.00
Powder for Hairloss Treatment Research
Price range: $135.00 through $500.00
Powder for Hairloss Treatment Research
Price range: $168.00 through $268.00
Sale!
Powder for Hairloss Treatment Research
Price range: $355.00 through $1,980.00
Sale!
Powder for Hairloss Treatment Research
Price range: $99.00 through $159.00
Reviews
There are no reviews yet.